In previous studies, we confirmed that hyperleptinemia is an independent risk factor for the development of PTDM, and a low level of adiponectin was associated with insulin resistance and obesity [15]. Here, ADIPOQ is linked to obesity due to melanocortin 4 receptor deficiency.